Expression analysis of human Cadherin-17 on HEK293/Human Cadherin-17 Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human Cadherin-17 Stable Cell Line or negative control cell using anti-human Cadherin-17 antibody followed by staining with FITC anti-mouse IgG antibody.
Anti-Cadherin-17 antibody captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Human Cadherin-17, His Tag (Cat. No. CA7-H52H3) with an affinity constant of 2.9 μM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
CHM-2101 | CDH17-CAR T; CHM-2101; CHM2101; CHM-2101 CAR-T cells | Phase 2 Clinical | University Of Pennsylvania | Stomach Neoplasms; Pancreatic Neoplasms; Neuroendocrine Tumors; Colorectal Neoplasms; Gastrointestinal Neoplasms | Details |
BI-905711 | BI-905711 | Phase 1 Clinical | Boehringer Ingelheim Gmbh | Pancreatic Neoplasms; Cholangiocarcinoma; Gastrointestinal Neoplasms | Details |
Cabotamig | ARB-202 | Phase 1 Clinical | Arbele Corp | Liver Neoplasms; Biliary Tract Neoplasms; Stomach Neoplasms; Pancreatic Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Esophageal adenocarcinoma; Gastrointestinal Neoplasms | Details |
Anti-CDH17 CAR-T Cell therapy(UTC Therapeutics) | Phase 1 Clinical | UTC Therapeutics Inc | Solid tumours | Details | |
TORL-3-600 | TORL-3-600 | Phase 1 Clinical | Torl Biotherapeutics LLC | Solid tumours; Colorectal Neoplasms | Details |
CDH17 - IHC Test(Arbele) | Clinical | Arbele Corp | Gastrointestinal Neoplasms | Details |
This web search service is supported by Google Inc.